Jan Debruyne - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jan Debruyne

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Brain : a Journal of Neurology|July 20, 2010

Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)Sean J Pittock, Jan Debruyne, Karl N Krecke, et al.

Trials|January 28, 2014

Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trialMelissa Cambron, Jop Mostert, Patrick Haentjens, et al.

Acta Neurologica Belgica|June 12, 2014

Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational programVincent van Pesch, Emmanuel Bartholomé, Véronique Bissay, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Brain : a Journal of Neurology|July 20, 2010

Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)Sean J Pittock, Jan Debruyne, Karl N Krecke, et al.

Trials|January 28, 2014

Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trialMelissa Cambron, Jop Mostert, Patrick Haentjens, et al.

Acta Neurologica Belgica|June 12, 2014

Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational programVincent van Pesch, Emmanuel Bartholomé, Véronique Bissay, et al.

Pageof 2